Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07615101 68Ga-NYM032 Prostatic Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07615101 clinical trial report covering 68Ga-NYM032, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07614152 Y-shape pegylated somatropin (Xiamen Amoytop Biotech) Dwarfism Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07614152 clinical trial report covering Y-shape pegylated somatropin (Xiamen Amoytop Biotech), Phase 3, endpoints, sponsor, geography, readout timing and d
Latest Hotspot
8 min read
NCT07613307 Orforglipron Diabetes Mellitus, Type 2 Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07613307 clinical trial report covering Orforglipron, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07613099 [18F]FAPI-74 Acute Lung Injury Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07613099 clinical trial report covering [18F]FAPI-74, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07613528 Progesterone Pregnancy Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07613528 clinical trial report covering Progesterone, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262153 Fluorofenidone Hepatitis B, Chronic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
CTR20262153 clinical trial report covering Fluorofenidone, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262075 Quadrivalent inactivated enterovirus vaccine(Sinovac Biotech) Hand, Foot and Mouth Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
CTR20262075 clinical trial report covering Quadrivalent inactivated enterovirus vaccine(Sinovac Biotech), Phase 3, endpoints, sponsor, geography, readout timi
Latest Hotspot
8 min read
NCT07616973 Clomiphene Citrate Infertility Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07616973 clinical trial report covering Clomiphene Citrate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
ChiCTR2600125798 Enzalutamide Metastatic castration-resistant prostate cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
ChiCTR2600125798 clinical trial report covering Enzalutamide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07616375 HSK-31858 Non-cystic fibrosis bronchiectasis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
NCT07616375 clinical trial report covering HSK-31858, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
ChiCTR2600125844 Albumin-Bound Paclitaxel Locally Advanced Cervical Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
ChiCTR2600125844 clinical trial report covering Albumin-Bound Paclitaxel, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
ChiCTR2600125893 Remimazolam Tosylate Neoplasms Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
22 July 2026
ChiCTR2600125893 clinical trial report covering Remimazolam Tosylate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.